Type 1 Diabetes Archives - Endocrinology Advisor

Xeris Pharmaceuticals announced the launch of Gvoke HypoPen™ (glucagon) for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 2 years and older.

Diabetes

Recommendations for Management of Diabetic Ketoacidosis in COVID-19

By

Amit Akirov, MD

June 29, 2020

A clinical perspective article details the recommended approach to manage diabetic ketoacidosis in patients with diabetes during the COVID-19 pandemic.

Diabetes

Benefits of Continuous Glucose Monitoring Systems in the Hospital Setting

By

Amit Akirov, MD

June 26, 2020

Continuous glucose monitoring is a safe and useful method to measure blood glucose levels in the hospital, especially during the COVID-19 pandemic.

Diabetes

Associations Between Pemphigus and Type 1 Diabetes, Type 2 Diabetes

By

Rachael Beairsto

June 26, 2020

The association of pemphigus with type 1 (T1DM) and type 2 diabetes mellitus (T2DM) is assessed.

Type 1 Diabetes

Hyperglycemia Common in Patients With T1D and COVID-19

June 25, 2020

Presentation patterns are similar in patients with type 1 diabetes admitted with confirmed or suspected COVID-19.

Type 1 Diabetes

Acute Hyperglycemia Impairs Spatial Working Memory in Adolescents With T1D

By

Rose Reeb

June 23, 2020

Acute hyperglycemia affects brain metabolite concentration and performance on spatial working memory tasks in adolescents with type 1 diabetes.

Diabetes

New Rapid-Acting Insulin Lispro Approved by FDA

By

Brian Park, PharmD

June 19, 2020

The FDA has approved Lyumjev™ (insulin lispro-aabc injection; Lilly) to improve glycemic control in adults with type 1 and type 2 diabetes.

Diabetes

FDA Approves Long-Acting Insulin Glargine Injection for T1D, T2D

By

Brian Park, PharmD

June 19, 2020

The FDA has approved Semglee™ (insulin glargine injection; Mylan and Biocon) to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.